top
Search terms
Results 91 - 100 of 157 - ordered by :
Pages: 1 ... 7 8 9 10 11 12 13 ... 16
Eurointervention

EuroIntervention Two-year clinical outcomes after treatment of saphenous vein graft with a new generation DES Ospedale Maggiore Policlinico, Milano, Italy Aims: To study the performance of Nobori, a ...

Date : 17/05/2011 Item size : 35901 bytes
Eurointervention

EuroIntervention Clinical efficacy of loading-dose sarpogrelate HCl on top of dual antiplatelet pretreatments in patients with acute ST-elevation myocardial infarction (STEMI) before primary ...

Date : 17/05/2011 Item size : 34304 bytes
Eurointervention

In France use of DES is mainly recommended for diabetic patients and treatment of small vessels and long lesions. Primary endpoint of the study was target lesion failure (TLF), a composite of ...

Date : 17/05/2011 Item size : 35133 bytes
Ehjqcco

Abstract Aims There is a paucity of real-world, contemporary data of practice patterns and clinical outcomes following dual-antiplatelet therapy (DAPT) in acute myocardial infarction (AMI) patients ...

European Heart Journal - Quality of Care and Clinical Outcomes, Original Article, Juan J. Russo, Shaun G. Goodman, Akshay Bagai, Jean-Pierre Déry, Mary K. Tan, Harold N. Fisher, Xiang Zhang, Yajun ...

Date : 15/10/2016 Item size : 316571 bytes
AnatolianJournal

Treatment of saphenous vein graft lesions with paclitaxel- and sirolimuseluting stents: comparison of short- and long-term clinical outcomes [Anatol J Cardiol] Selçuk Görmez1, Refik Erdim1, ...

Date : 12/01/2017 Item size : 36364 bytes
AnatolianJournal

The first six-month clinical outcomes and risk factors associated with high on-treatment platelet reactivity of clopidogrel in patients undergoing coronary interventions [Anatol J Cardiol] Ahmet ...

Date : 13/01/2017 Item size : 38332 bytes
Ehjournal

Clopidogrel replaced ticlopidine as a safer thienopyridine for P2Y12 inhibition, but does not have universal efficacy due to poor efficiency of active metabolite formation in some individuals, only ...

European Heart Journal, Editorial, Robert F. Storey

Date : 14/07/2015
Ehjournal

Methods and results Patients (N = 1799) who had undergone placement of 1 DES for stable coronary artery disease or acute coronary syndrome were included in 58 French sites (January 2009January ...

European Heart Journal, FASTTRACK CLINICAL RESEARCH, Gérard Helft, Philippe Gabriel Steg, Claude Le Feuvre, Jean-Louis Georges, Didier Carrie, Xavier Dreyfus, Alain Furber, Florence Leclercq, ...

Date : 21/01/2016
Ehjournal

The field of percutaneous coronary intervention (PCI) remains extremely active, with major advances involving revascularisation strategies and techniques, adjuvant antithrombotic therapy (with a ...

European Heart Journal, CURRENT OPINION, Philippe Gabriel Steg, Patrick W. Serruys, Mohammad Abdelghani, William Wijns

Date : 21/01/2016
Ehjcvp

Abstract Aims Clinical utilization of dual antiplatelet therapy (DAPT) in patients with renal impairment (RI) following percutaneous coronary interventions (PCI) represents an urgent, unmet need ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLES, Long Zhe Guo, Moo Hyun Kim, Chang Heon Shim, Sun Young Choi, Victor L. Serebruany

Date : 01/07/2016